SMARCB1 and large cell neuroendocrine carcinoma: SMARCB1 loss was detected in most of these cases (9/11), including eight SCCs and one mixed neuroendocrine/non-neuroendocrine neoplasm (MiNEN), composed of a LCNEC and a NKSCC.